Ausgabe 3/2011
Inhalt (6 Artikel)
Should persons with autosomal dominant AD be included in clinical trials?
Joshua D Grill, John M Ringman
Should persons with autosomal dominant AD be included in clinical trials? Authors' response
Kinga Szigeti, Rachelle S Doody
The β-secretase enzyme BACE1 as a therapeutic target for Alzheimer's disease
Robert Vassar, Patty C Kandalepas
Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
Jake G Hoekstra, Kathleen S Montine, Jing Zhang, Thomas J Montine
Analyzing the impact of 23 mg/day donepezil on language dysfunction in moderate to severe Alzheimer's disease
Steven H Ferris, Frederick A Schmitt, Judith Saxton, Sharon Richardson, Joan Mackell, Yijun Sun, Yikang Xu